Jian‐Yi Wu

3.4k total citations
80 papers, 1.6k citations indexed

About

Jian‐Yi Wu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Jian‐Yi Wu has authored 80 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 24 papers in Surgery and 19 papers in Oncology. Recurrent topics in Jian‐Yi Wu's work include Esophageal Cancer Research and Treatment (22 papers), Cancer-related gene regulation (16 papers) and Microbial metabolism and enzyme function (7 papers). Jian‐Yi Wu is often cited by papers focused on Esophageal Cancer Research and Treatment (22 papers), Cancer-related gene regulation (16 papers) and Microbial metabolism and enzyme function (7 papers). Jian‐Yi Wu collaborates with scholars based in China, United States and Canada. Jian‐Yi Wu's co-authors include En‐Min Li, Li‐Yan Xu, Zhi‐Yong Wu, Xiu‐E Xu, Jin‐Hui Shen, Shaohong Wang, Lian‐Di Liao, Jian‐Jun Xie, Bingli Wu and John M. Miller and has published in prestigious journals such as PLoS ONE, Circulation Research and Cancer Research.

In The Last Decade

Jian‐Yi Wu

77 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Yi Wu China 26 950 369 288 284 238 80 1.6k
Tobias G. Schips United States 18 940 1.0× 238 0.6× 259 0.9× 219 0.8× 134 0.6× 20 1.7k
Heyu Zhang China 25 868 0.9× 296 0.8× 201 0.7× 325 1.1× 191 0.8× 88 1.8k
Mary Jo Mulligan‐Kehoe United States 18 616 0.6× 188 0.5× 237 0.8× 158 0.6× 227 1.0× 26 1.5k
Sean F. Hackett United States 27 2.0k 2.1× 345 0.9× 204 0.7× 504 1.8× 114 0.5× 45 3.3k
José M. Larios United States 14 676 0.7× 220 0.6× 159 0.6× 319 1.1× 486 2.0× 22 1.6k
Hee Jin Kwak South Korea 16 1.3k 1.3× 481 1.3× 178 0.6× 294 1.0× 120 0.5× 21 1.9k
Bryan D. Maliken United States 14 922 1.0× 187 0.5× 447 1.6× 260 0.9× 172 0.7× 20 1.9k
Liming Yu China 31 1.3k 1.4× 385 1.0× 200 0.7× 218 0.8× 95 0.4× 61 2.1k
Santiago Miriuka Argentina 26 913 1.0× 176 0.5× 484 1.7× 156 0.5× 124 0.5× 81 1.9k
Xiaoli Sun China 20 521 0.5× 209 0.6× 212 0.7× 171 0.6× 225 0.9× 59 1.6k

Countries citing papers authored by Jian‐Yi Wu

Since Specialization
Citations

This map shows the geographic impact of Jian‐Yi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Yi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Yi Wu more than expected).

Fields of papers citing papers by Jian‐Yi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Yi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Yi Wu. The network helps show where Jian‐Yi Wu may publish in the future.

Co-authorship network of co-authors of Jian‐Yi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Yi Wu. A scholar is included among the top collaborators of Jian‐Yi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Yi Wu. Jian‐Yi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
He, Jianzhong, Yang Chen, Fa‐Min Zeng, et al.. (2023). Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 136–136. 17 indexed citations
5.
Cheng, Yinwei, Fa‐Min Zeng, Shaohong Wang, et al.. (2021). P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer. Cancer Communications. 41(12). 1398–1416. 22 indexed citations
6.
Jiao, Jiwei, Haifeng Zhang, Xiu‐E Xu, et al.. (2019). LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion. Cancer Research. 79(19). 4951–4964. 53 indexed citations
7.
Huang, Pei-Qi, Bingli Wu, Sijie Chen, et al.. (2019). Clinical significance of LOXL4 expression and features of LOXL4-associated protein–protein interaction network in esophageal squamous cell carcinoma. Amino Acids. 51(5). 813–828. 11 indexed citations
8.
He, Jianzhong, Shaohong Wang, Xuefeng Bai, et al.. (2018). MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma. British Journal of Cancer. 118(11). 1476–1484. 12 indexed citations
9.
Xu, Yi‐Wei, Chao‐Qun Hong, Zhi‐Yong Wu, et al.. (2018). Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma. Clinics and Research in Hepatology and Gastroenterology. 42(6). 597–603. 6 indexed citations
10.
Sun, Hong, Xinyi Cai, Xiaoqi Li, et al.. (2018). The protein–protein interaction network and clinical significance of heat-shock proteins in esophageal squamous cell carcinoma. Amino Acids. 50(6). 685–697. 9 indexed citations
11.
Long, Lin, Xiaoxiao Pang, Fei Lei, et al.. (2018). SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer. Cellular and Molecular Life Sciences. 75(14). 2643–2661. 42 indexed citations
12.
13.
Fang, Wang‐Kai, Bo Chen, Xiu‐E Xu, et al.. (2014). Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma. Acta Histochemica. 116(5). 803–809. 10 indexed citations
14.
Wu, Bingli, Chunquan Li, Jian‐Jun Xie, et al.. (2013). Comprehensive Bioinformation Analysis of the MRNA Profile of Fascin Knockdown in Esophageal Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 14(12). 7221–7227. 8 indexed citations
15.
Wu, Bingli, Chunquan Li, Qianlan Yao, et al.. (2013). Dissection of miRNA-miRNA Interaction in Esophageal Squamous Cell Carcinoma. PLoS ONE. 8(9). e73191–e73191. 25 indexed citations
16.
Zhang, Haifeng, Kai Zhang, Lian‐Di Liao, et al.. (2013). miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. Carcinogenesis. 35(2). 292–301. 47 indexed citations
17.
Sun, Lingling, Xiu‐E Xu, Mengxiao Zhu, et al.. (2012). Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma. Acta Histochemica. 115(1). 56–62. 26 indexed citations
18.
Jin, Lin, et al.. (2011). Stock Reform of Shenzhen Development Bank. SSRN Electronic Journal. 1 indexed citations
19.
Xie, Jian‐Jun, Li‐Yan Xu, Zhi‐Yong Wu, et al.. (2011). Prognostic implication of ezrin expression in esophageal squamous cell carcinoma. Journal of Surgical Oncology. 104(5). 538–543. 33 indexed citations
20.
Lopshire, John C., et al.. (2004). Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction. Heart Rhythm. 1(4). 451–459. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias G. Schips Breakdown of academic impact, for papers by Heyu Zhang Breakdown of academic impact, for papers by Mary Jo Mulligan‐Kehoe Breakdown of academic impact, for papers by Sean F. Hackett Breakdown of academic impact, for papers by José M. Larios Breakdown of academic impact, for papers by Hee Jin Kwak Breakdown of academic impact, for papers by Bryan D. Maliken Breakdown of academic impact, for papers by Liming Yu Breakdown of academic impact, for papers by Santiago Miriuka Breakdown of academic impact, for papers by Xiaoli Sun
Rankless by CCL
2026